Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC). These developments include exciting, if preliminary, results relating to the effect of THC on amyloid-beta plaques—which are the plaques on neurons associated with Alzheimer’s disease—and a critical link between the related technology and IGC.
“This information was summarized in an article first published on Benzinga (http://nnw.fm/6SSZi) and recently adapted for HIGH TIMES (http://nnw.fm/7AZcm), titled ‘Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work.’
“Details from these articles include:
- A paper published by the Salk Institute has validated a study by the University of South Florida, indicating that low doses of THC (one of the main chemical compounds present in marijuana) break up amyloid-beta plaques on neurons.
- The prestigious journal Nature then published a paper showing that “cognitive function was restored in old mice who were given low doses of THC.”
- After discovering that THC in low doses binds to amyloid-beta plaques, preventing them from aggregating on neurons, the University of South Florida filed a patent for that mechanism.
- Following intensive negotiations, India Globalization Capital, a diverse Maryland-headquartered company now focused on the development of cannabis-based therapies, bought the exclusive rights to that U.S. patent filing.”
To view the full article, visit http://nnw.fm/8LsVY.
About India Globalization Capital
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in humans, dogs and cats. In support of this effort, IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us.
More from NetworkNewsBreaks
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.com